angiotensin ii has been researched along with perindopril in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (8.33) | 18.7374 |
1990's | 35 (41.67) | 18.2507 |
2000's | 28 (33.33) | 29.6817 |
2010's | 14 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Janiak, P; Pillon, A; Prost, JF; Vilaine, JP | 1 |
Higaki, J; Higashimori, K; Katahira, K; Mikami, H; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T | 1 |
Aalkjaer, C; Kvist, S; Mulvany, MJ | 1 |
Griffin, SA; Harrap, SB; Lever, AF; Macpherson, F; Van der Merwe, WM | 1 |
Chai, SY; Jackson, B; Johnson, CI; Mendelsohn, FA; Sakaguchi, K | 1 |
Brunner, HR; Nussberger, J; Perret, L; Santoni, JP; Waeber, B | 1 |
Brunner, HR; Nussberger, J; Waeber, B | 1 |
Chardigny, JM; Diebold, H; Moreau, D; Rochette, L | 1 |
Bidiville, J; Brunner, HR; Bussien, JP; Nussberger, J; Porchet, M; Waeber, B | 1 |
Ganten, D; Lang, RE; Moursi, MG; Unger, T | 1 |
Doyle, AE; Harrap, SB; Torresi, J | 1 |
Bertram, JF; Black, MJ; Campbell, GR; Campbell, JH | 1 |
Franco-Saenz, R; Mulrow, PJ; Oda, H; Tokita, Y | 1 |
Bertram, JF; Black, MJ; Bobik, A; O'Sullivan, JB | 1 |
Janiak, P; Libert, O; Vilaine, JP | 1 |
Campbell, DJ; Duncan, AM; Kladis, A | 2 |
Bartenbach, S; Gohlke, P; Kuwer, I; Lamberty, V; Linz, W; Schnell, A; Schölkens, BA; Unger, T; Wiemer, G | 1 |
Black, MJ; Campbell, GR; Campbell, JH | 1 |
Casley, DJ; Doyle, AE; Harrap, SB; Mirakian, C; Mitchell, GA | 1 |
Higaki, J; Higashimori, K; Mikami, H; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T | 1 |
Chauvin, B; Giudicelli, JF; Richer, C | 1 |
Campbell, DJ; Duncan, AM; Harrap, SB; Kladis, A | 1 |
Anderson, NH; Bohr, DF; Devlin, AM; Dominiczak, AF; Lee, WK; Reid, JL | 1 |
Cooper, ME; Komers, R; Rumble, JR | 1 |
Compagnon, P; Desché, P; Devaux, B; Elfertak, L; Henry, JP; Macé, B; Mulder, P; Richard, V; Scalbert, E; ThuilleZ, C | 1 |
Benzoni, D; Liu, KL; Sassard, J | 1 |
Franco-Saenz, R; Mulrow, PJ; Tokita, Y | 1 |
Dusting, GJ; Hickey, H; Hyland, R; Makdissi, M; Wilks, D | 1 |
Burrell, LM; Campbell, DJ; Duncan, AM; Kladis, A | 1 |
Casley, D; Mendelsohn, FA; Murone, C; Zhuo, J | 1 |
Buxton, B; Casley, D; Chai, SY; Froomes, P; Liu, JJ; Mendelsohn, FA; Murone, C; Zhuo, JL | 1 |
Barr, CS; Fenwick, M; MacFadyen, RJ; Struthers, AD; Sturrock, ND | 1 |
Black, MJ; Bobik, A; Kanellakis, P | 1 |
Lantelme, P; Lo, M; Luttenauer, L; Sassard, J | 1 |
Cerutti, C; Ducher, M; Lantelme, P; Lo, M; Paultre, CZ | 1 |
Gorodetskaya, EA; Kalenikova, EI; Medvedev, OS; Shechter, AB; Zacharova, NV | 1 |
Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Duncan, AM; James, GM; Kladis, A | 1 |
Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
Altun, B; Arici, M; Cağlar, S; Erdem, Y; Haznedaroğlu, IC; Turgan, C; Usalan, C; Yasavul, U | 1 |
Cicutti, N; Guez, D; Maurin, A; Rakusan, K; Schiavi, P | 1 |
Lantelme, P; Lo, M; Sassard, J | 1 |
Liang, Q; Tang, J; Wu, C; Zhou, Q | 1 |
Henrion, D; Lévy, BI; Matrougui, K | 1 |
Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
Head, GA; Minami, N | 1 |
Iwao, H; Izumi, Y; Kim, S; Yano, M; Yasumoto, H; Zhan, Y | 1 |
Cooper, ME; Cox, AJ; Gilbert, RE; Hendrich, EC; Jerums, G; Kelly, DJ; Lee, V; Osicka, T; Panagiotopoulos, S; Rumble, JR; Wilkinson-Berka, JL | 1 |
Duhault, J; Lonchampt, M; Pennel, L | 1 |
Paull, JR; Widdop, RE | 1 |
Fukui, H; Ikenaka, Y; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yoshii, J; Yoshiji, H | 1 |
Delbridge, LM; Griffiths, CD; Morgan, TO | 1 |
Gálvez, A; Jalil, JE; Lavandero, S; Ocaranza, MP | 1 |
Ditiatkov, AE; Radzevich, AE; Tikhonov, VA | 1 |
Chen, X; Liu, SK; You, JL; Zhou, M | 1 |
Liu, G; Wang, X; Yang, C; Zeng, C | 1 |
Wu, XY; Zhong, HJ; Zhou, M | 1 |
Delbridge, LM; Morgan, TO; Trongtorsak, P | 1 |
Li, X; Meng, Y; Wu, PS; Yang, XS; Zhang, ZS; Zou, JL | 1 |
Hirata, Y | 1 |
Chan, JS; Fantus, IG; Filep, JG; Fustier, P; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Tang, SS; Wei, CC; Zhang, SL | 1 |
Boasquevisque, EM; de Lourdes Rodrigues, M; Francischetti, EA; Genelhu, V; Ismerim, VL; Matos, JP | 1 |
Benzoni, D; Liu, KL; Lo, M | 1 |
Bertrand, M; Blann, A; Ceconi, C; Cokkinos, D; Ferrari, R; Fox, KM; Kluft, C; Parrinello, G; Remme, WJ; Simoons, ML | 1 |
Aggarwal, A; Ahimastos, AA; D'Orsa, KM; Dart, AM; Formosa, MF; Kingwell, BA; Savarirayan, R; White, AJ | 1 |
Begg, DP; Chen, N; Jayasooriya, AP; Mathai, ML; Sinclair, AJ; Wark, JD; Weisinger, HS; Weisinger, RS; Wilkinson-Berka, J | 1 |
Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
Benzoni, D; Issiakhem, M; Liu, KL | 1 |
Cho, CS; Kim, JH; Kim, KW; Yu, YS | 1 |
Huang, ML; Li, X; Ma, Q; Meng, Y; Wu, PS; Xiao, B; Ying, SS; Zhang, ZS | 1 |
Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E | 2 |
Ceconi, C; Ferrari, R; Guardigli, G | 1 |
Coletta, E; Davies, R; Haddad, H; Leenen, FH; Ruzicka, M; White, R | 1 |
Chou, PC; Hsiao, PJ; Hsieh, TJ; Hung, WW; Lin, KD; Lin, T; Shin, SJ | 1 |
Campbell, DJ; Gilbert, RE; Kelly, DJ; McCarthy, DJ; Shi, W; Smyth, GK; Zhang, Y | 1 |
Li, L; Lu, W; Shang, D; Zhang, T; Zhou, T; Zhou, X | 1 |
Hattori, Y; Hayashi, T; Kuzuya, M; Maeda, M; Sakakibara, Y; Taguchi, K; Yamaguchi, T | 1 |
Bhat, SA; Goel, R; Hanif, K; Nath, C; Rajasekar, N; Shukla, R | 1 |
El-Shoura, EAM; Hemeida, RAM; Messiha, BAS; Sharkawi, SMZ | 1 |
Cai, Y; Deng, H; Feng, Q; Li, Z; Qiu, S; Tian, W; Wang, X; Wang, Y; Wu, J | 1 |
Abd El-Rahman, SS; Fayed, HM | 1 |
Ha, AW; Kim, HR; Kim, WK | 1 |
4 review(s) available for angiotensin ii and perindopril
Article | Year |
---|---|
Experience with perindopril in normal volunteers.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Administration Schedule; Humans; Indoles; Peptidyl-Dipeptidase A; Perindopril; Renin-Angiotensin System | 1989 |
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
[NO and hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Arteriosclerosis; Biopterins; C-Reactive Protein; Endothelium, Vascular; Humans; Hypertension; Mutation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species; Vasodilation | 2004 |
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells | 2010 |
8 trial(s) available for angiotensin ii and perindopril
Article | Year |
---|---|
Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Autoradiography; Endothelium, Vascular; Hemodynamics; Humans; In Vitro Techniques; Indoles; Mammary Arteries; Middle Aged; Myocardial Ischemia; Peptidyl-Dipeptidase A; Perindopril | 1997 |
Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure.
Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output, Low; Chronic Disease; Depression, Chemical; Female; Humans; Indoles; Kidney Function Tests; Male; Middle Aged; Perindopril | 1997 |
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Hypertension; Lipoproteins; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator | 1999 |
Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Perindopril; Renin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2005 |
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
Topics: Aged; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Biomarkers; Bradykinin; Cells, Cultured; Coronary Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Male; Microscopy, Fluorescence; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Perindopril; Proportional Hazards Models; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2007 |
Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta; Arteries; Blood Flow Velocity; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Male; Marfan Syndrome; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Perindopril; Transforming Growth Factor beta; Ultrasonography, Doppler; Vasodilation | 2007 |
Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta, Thoracic; Cardiac Catheterization; Coronary Sinus; Female; Humans; Hydrophobic and Hydrophilic Interactions; Hypertension; Lipids; Lisinopril; Male; Middle Aged; Perindopril; Prospective Studies; Pulmonary Wedge Pressure; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines; Young Adult | 2010 |
72 other study(ies) available for angiotensin ii and perindopril
Article | Year |
---|---|
Role of angiotensin subtype 2 receptor in neointima formation after vascular injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Carotid Artery Injuries; Catheterization; Hyperplasia; Imidazoles; Indoles; Losartan; Male; Oligopeptides; Perindopril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Tunica Intima | 1992 |
Regression of left ventricular hypertrophy by angiotensin converting enzyme inhibitor in reduced renal mass hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Heart Ventricles; Hypertension, Renal; Indoles; Male; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin | 1991 |
Studies of the renin-angiotensin system in the wall of rat femoral resistance vessels.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Enzyme Precursors; Femoral Artery; In Vitro Techniques; Indoles; Kallikreins; Male; Muscle, Smooth, Vascular; Norepinephrine; Oligopeptides; Perindopril; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Saralasin; Vascular Resistance | 1991 |
Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Vessels; Cardiovascular Physiological Phenomena; Hemodynamics; Hypertension; Indoles; Perindopril; Rats; Rats, Inbred SHR; Time Factors | 1990 |
Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Autoradiography; Blood Pressure; Indoles; Kidney; Lung; Male; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred Strains; Testis; Time Factors | 1988 |
[Direct cardiac effects of angiotensins I and II and 2 converting enzyme inhibitors (captopril and perindopril). Indirect demonstration of a converting enzyme in the rat heart].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Coronary Circulation; Coronary Disease; Heart; Heart Rate; Indoles; Male; Myocardium; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Saralasin | 1988 |
Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Cilazapril; Humans; Indoles; Male; Perindopril; Pyridazines | 1987 |
Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Hypertension; Indoles; Male; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin-Angiotensin System | 1986 |
Pressor sensitivity to angiotensin I and angiotensin II during the development of experimental renal hypertension in the rat.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension, Renal; Indoles; Male; Oligopeptides; Perindopril; Pressoreceptors; Rats; Rats, Inbred Strains; Teprotide | 1986 |
Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arterioles; Cardiovascular System; Hypertrophy; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Ploidies; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Splanchnic Circulation | 1995 |
Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
Topics: Adrenal Glands; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Indoles; Infusions, Parenteral; Kidney; Male; Perindopril; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System | 1995 |
Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Hypertension, Renovascular; Hypertrophy; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred WKY; Tetrazoles | 1994 |
Role of the renin-angiotensin system in neointima formation after injury in rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Heart Rate; Imidazoles; Indoles; Losartan; Male; Oligopeptides; Perindopril; Rabbits; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Tunica Intima; Wound Healing | 1994 |
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Topics: Adipose Tissue, Brown; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Aorta; Bradykinin; Indoles; Kidney; Lisinopril; Lung; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Sprague-Dawley; Renin | 1994 |
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
Topics: Aging; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hypertension; In Vitro Techniques; Indoles; Maternal-Fetal Exchange; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Pregnancy; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Systole | 1993 |
Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR | 1993 |
Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Sodium | 1993 |
Bradykinin peptides in kidney, blood, and other tissues of the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Chromatography, High Pressure Liquid; Indoles; Kidney; Male; Peptides; Perindopril; Radioimmunoassay; Rats; Tissue Distribution | 1993 |
The angiotensin-converting enzyme inhibitor, perindopril, prevents cardiac hypertrophy in low-renin hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension, Renal; Hypertrophy, Left Ventricular; Indoles; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Radioimmunoassay; Rats; Rats, Wistar; Renin; Sodium Chloride | 1993 |
Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Decerebrate State; Hemodynamics; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Vasoconstriction | 1995 |
Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Hypertension; Indoles; Male; Peptide Fragments; Perindopril; Radioimmunoassay; Rats; Rats, Inbred SHR; Renin; Tissue Distribution | 1995 |
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Female; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Polyploidy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Diabetic Angiopathies; Hypertrophy; Indoles; Kinins; Male; Mesenteric Arteries; Nitric Oxide; Nitroarginine; Perindopril; Rats; Rats, Wistar | 1996 |
Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Endothelium, Vascular; Femoral Artery; Hemodynamics; In Vitro Techniques; Indoles; Male; Myocardial Infarction; Nitroprusside; Perindopril; Rats; Rats, Wistar; Vasodilator Agents | 1996 |
In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Hypertension; Indoles; Kidney; Male; Natriuresis; Perfusion; Perindopril; Pressure; Rats; Rats, Inbred Strains; Receptors, Thromboxane; Reference Values; Renal Circulation; Time Factors; Vasoconstriction | 1996 |
Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Topics: Adrenal Glands; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antibodies; Blood Pressure; Hypertension; Indoles; Kidney; Male; Mice; Perindopril; Rats; Renin; Renin-Angiotensin System | 1995 |
Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Carotid Arteries; Disease Models, Animal; Endothelium, Vascular; Hemodynamics; In Vitro Techniques; Indoles; Nitric Oxide; Peptidyl-Dipeptidase A; Perindopril; Rabbits; Serotonin; Vasoconstriction; Vasodilation | 1996 |
Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Heart; Indoles; Male; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley | 1996 |
Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteries; Autoradiography; Blood Pressure; Carotid Arteries; Endothelium, Vascular; Femoral Artery; Indoles; Kidney; Lung; Male; Myocardium; Peptidyl-Dipeptidase A; Perindopril; Rabbits; Renin | 1997 |
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body Weight; Cardiomegaly; Cardiovascular System; Hypertension; Hypertrophy; Indoles; Kidney; Losartan; Male; Mesenteric Arteries; Organ Size; Papaverine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance | 1997 |
Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiac Output; Enzyme Precursors; Heart Rate; Hemodynamics; Hypertension; Indoles; Kidney Cortex; Male; Perindopril; Rats; Rats, Inbred Strains; Regional Blood Flow; Renin; Renin-Angiotensin System; Vascular Resistance | 1997 |
Mechanisms of spontaneous baroreflex impairment in lyon hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Indoles; Losartan; Male; Perindopril; Rats | 1998 |
Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Chromatography, High Pressure Liquid; Hemodynamics; Indoles; Infusions, Intravenous; Lung; Male; Microspheres; Perindopril; Rats; Rats, Wistar | 1998 |
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomegaly; Cyclic GMP; Drug Synergism; Indoles; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Perindopril; Potassium; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan | 1999 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Blood Pressure; Capillaries; Coronary Vessels; Diuretics; Drug Synergism; Heart; Hypertension; Indapamide; Male; Myocardium; Perindopril; Rats; Rats, Inbred SHR | 2000 |
Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diastole; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Kidney Cortex; Male; Norepinephrine; Perindopril; Rats; Renin; Renin-Angiotensin System; Sodium; Systole; Time Factors | 2000 |
Effects of perindopril on vascular wall and left ventricular hypertrophy in rats with experimental hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Artery, Superior; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley | 1998 |
Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Viscosity; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Imidazoles; Losartan; Mesenteric Arteries; Muscle Tonus; Perindopril; Phenylpropionates; Pyridines; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Splanchnic Circulation; Vascular Resistance; Vasodilation | 2000 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Cardiac vagal responsiveness during development in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Baroreflex; Bradycardia; Electric Stimulation; Heart; Heart Rate; Hypertension; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Respiration; Respiration, Artificial; Vagus Nerve | 2000 |
In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Enalapril; ErbB Receptors; Hypertension; Infusions, Intravenous; Male; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Perindopril; Phosphorylation; Rats; Rats, Inbred SHR; Receptors, Platelet-Derived Growth Factor | 2000 |
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Gene Expression; In Situ Hybridization; Lymphokines; Male; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Cell Count; Dextrans; Endothelium; Fluoresceins; Humans; Hyperoxia; Hypoxia; Imidazoles; Infant, Newborn; Losartan; Mice; Mice, Inbred C57BL; Perindopril; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Retinal Ganglion Cells; Retinal Neovascularization; Retinopathy of Prematurity | 2001 |
Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Vessels; Cardiomegaly; Cardiovascular System; Drug Administration Schedule; Heart Rate; Hydralazine; Hypertension; Kidney; Male; Motor Activity; Perindopril; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Vasodilator Agents | 2001 |
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Endothelial Growth Factors; Immunohistochemistry; Liver Cirrhosis, Experimental; Lymphokines; Male; Perindopril; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Blood; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Drug Synergism; Eating; Heart; Losartan; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2001 |
[Early prevention of experimental left ventricular hypertrophy in experimental hypertension and angiotensin II levels].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Drug Evaluation, Preclinical; Hypertension; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Sprague-Dawley | 2001 |
[Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Emotions; Heart Failure; Hemodynamics; Humans; Perindopril; Pulmonary Heart Disease; Quality of Life; Ramipril; Socioeconomic Factors; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2001 |
[Protective effect of perindopril on dysfunction of endothelium-dependent relaxation in diabetic rats].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Endothelium, Vascular; Male; Perindopril; Rats; Rats, Sprague-Dawley; Vasodilation | 2000 |
Effects of ACE inhibitor and beta-adrenergic blocker on plasma NPY and NPY receptors in aortic vascular smooth muscle cells from SHR and WKY rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Dose-Response Relationship, Drug; Immunoassay; Male; Metoprolol; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neuropeptide Y; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y | 2002 |
[Changes of ultrastructure and function of the aortic endothelium in streptozotocin-diabetic rats and effect of perindopril].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium, Vascular; Male; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley | 2001 |
Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Dose-Response Relationship, Drug; Heart; Losartan; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium, Dietary | 2003 |
[Perindopril attenuates the progression of CCl4-inducing rat hepatic fibrosis].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Becaplermin; Blotting, Western; Carbon Tetrachloride; Liver; Liver Cirrhosis, Experimental; Male; Perindopril; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Azaserine; Cell Line; Gene Expression Regulation; Glucose; Imidazoles; Indicators and Reagents; Indoles; Insulin; Kidney Tubules, Proximal; Losartan; Maleimides; Perindopril; Protein Kinase C; Pyridines; Rats; Reactive Oxygen Species; Renin | 2004 |
Effect of perindopril on renal medullary hemodynamics in genetically hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Hypertension, Renal; Indomethacin; Kidney Medulla; Male; Perindopril; Rats; Rats, Mutant Strains; Renal Circulation; Vasoconstrictor Agents | 2006 |
Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats.
Topics: Adipose Tissue; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Eating; Fatty Acids, Omega-3; Hypertension; Male; Perindopril; Rats; Renin | 2008 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Effect of perindopril on renal medullary blood flow: comparison with other antihypertensive treatments.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Kidney Medulla; Male; Nitric Oxide; Perindopril; Rats | 2008 |
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Retinal Barrier; Capillary Permeability; Cell Line; Dextrans; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Fluoresceins; Humans; Mice; Mice, Inbred C57BL; Perindopril; Retina; Tight Junctions; Vascular Endothelial Growth Factor A | 2009 |
Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Connective Tissue Growth Factor; Drug Interactions; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Perindopril; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Up-Regulation | 2010 |
Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blotting, Western; Butadienes; Cyclic N-Oxides; Extracellular Signal-Regulated MAP Kinases; Hydralazine; Male; Mesenteric Arteries; Mice; Mice, Knockout; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitriles; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Spin Labels; Tetrazoles; Vascular Resistance; Vasodilator Agents | 2010 |
Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Hypertension; Mesenteric Arteries; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apelin; Captopril; Cells, Cultured; Imidazoles; Intercellular Signaling Peptides and Proteins; Lipid Metabolism; Losartan; Mice; Perindopril; Pyridines; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; RNA, Messenger | 2011 |
Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
Topics: Aldosterone; Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Female; Fumarates; Heart; Kallikreins; Kidney; Lung; Mice; Myocytes, Cardiac; Perindopril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tissue Kallikreins | 2011 |
Modeling of angiotensin II-angiotensin-(1-7) counterbalance in disease progression in spontaneously hypertensive rats treated with/without perindopril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Male; Models, Biological; Peptide Fragments; Perindopril; Rats; Rats, Inbred SHR | 2012 |
eNOS-dependent antisenscence effect of a calcium channel blocker in human endothelial cells.
Topics: Angiotensin II; Antihypertensive Agents; Atenolol; beta-Galactosidase; Calcium Channel Blockers; Cellular Senescence; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Nifedipine; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species | 2014 |
Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebral Cortex; Hippocampus; Hypertension; Inflammation Mediators; Lipopolysaccharides; Male; Maze Learning; Memory Disorders; Motor Activity; Nerve Degeneration; Oxidative Stress; Peptidyl-Dipeptidase A; Perindopril; Rats | 2015 |
Perindopril ameliorates lipopolysaccharide-induced brain injury through modulation of angiotensin-II/angiotensin-1-7 and related signaling pathways.
Topics: Angiotensin I; Angiotensin II; Animals; Biomarkers; Brain; Brain Injuries; Glutathione; Lipopolysaccharides; Male; Malondialdehyde; Peptide Fragments; Perindopril; Rats; Rats, Wistar; Signal Transduction; Transcription Factor RelA | 2018 |
Ultrasound-Stimulated Microbubbles Enhance Radiosensitization of Nasopharyngeal Carcinoma.
Topics: Angiotensin II; Animals; Antigens, CD34; Benzimidazoles; Biphenyl Compounds; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contrast Media; Female; Gamma Rays; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Microbubbles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Perindopril; Receptor, Angiotensin, Type 1; Sonication; Tetrazoles | 2018 |
Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat.
Topics: Angiotensin II; Animals; Liver Cirrhosis; Male; Perindopril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Thioacetamide | 2019 |
Effects of Phytochemicals on Blood Pressure and Neuroprotection Mediated Via Brain Renin-Angiotensin System.
Topics: Acetylcholine; Acetylcholinesterase; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Curcumin; Male; Mice, Inbred ICR; Neuroprotection; Peptidyl-Dipeptidase A; Perindopril; Phytochemicals; Plant Extracts; Quercetin; Renin; Renin-Angiotensin System; RNA, Messenger; Saponins | 2019 |